Does the media prefer FUM or OBD?

In the previous week, Futura Medical and Futura Medical both had 1 articles in the media. Futura Medical's average media sentiment score of 0.00 equaled Oxford BioDynamics'average media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Futura Medical 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Oxford BioDynamics 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer TLM or FUM?

In the previous week, Talisman Metals and Talisman Metals both had 1 articles in the media. Talisman Metals' average media sentiment score of 0.21 beat Futura Medical's score of 0.00 indicating that Talisman Metals is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Talisman Metals 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Futura Medical 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has better earnings & valuation, FUM or BNR?

Burning Rock Biotech has lower revenue, but higher earnings than Futura Medical. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Futura Medical £1.70M 1.51 -£3.88M -£2.78 N/A Burning Rock Biotech N/A N/A N/A N/A N/A

Is FUM or NFX more profitable?

Nuformix has a net margin of 0.00% compared to Futura Medical's net margin of -534.62%. Nuformix's return on equity of -83.53% beat Futura Medical's return on equity. Company Net Margins Return on Equity Return on Assets Futura Medical -534.62% -310.00% -26.59% Nuformix N/A -83.53% -17.20%

Futura Medical (FUM) Competitors

GBX 0.44 -0.04 (-8.90%)

As of 08:13 AM Eastern

Compare

FUM vs. OBD, TLM, BNR, NFX, and MTFB

Should you buy Futura Medical stock or one of its competitors? Futura Medical's main competitors and comparable companies include Oxford BioDynamics (OBD), Talisman Metals (TLM), Burning Rock Biotech (BNR), Nuformix (NFX), and Motif Bio (MTFB). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "biotechnology" industry.

How does Futura Medical compare to Oxford BioDynamics?

Futura Medical (LON:FUM) and Oxford BioDynamics (LON:OBD) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, analyst recommendations, valuation, profitability, earnings, dividends and risk.

Futura Medical has a net margin of -534.62% compared to Oxford BioDynamics' net margin of -825.61%. Futura Medical's return on equity of -310.00% beat Oxford BioDynamics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Futura Medical	-534.62%	-310.00%	-26.59%
Oxford BioDynamics	-825.61%	-451.74%	-56.23%

In the previous week, Futura Medical and Futura Medical both had 1 articles in the media. Futura Medical's average media sentiment score of 0.00 equaled Oxford BioDynamics'average media sentiment score.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Futura Medical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Oxford BioDynamics	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Futura Medical has a beta of 0.021, suggesting that its share price is 98% less volatile than the broader market. Comparatively, Oxford BioDynamics has a beta of 0.42, suggesting that its share price is 58% less volatile than the broader market.

Futura Medical has higher revenue and earnings than Oxford BioDynamics. Oxford BioDynamics is trading at a lower price-to-earnings ratio than Futura Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Futura Medical	£1.70M	1.51	-£3.88M	-£2.78	N/A
Oxford BioDynamics	£1.20M	4.85	-£103.52M	-£0.20	N/A

1.0% of Futura Medical shares are owned by institutional investors. Comparatively, 11.6% of Oxford BioDynamics shares are owned by institutional investors. 16.0% of Futura Medical shares are owned by company insiders. Comparatively, 15.6% of Oxford BioDynamics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

Futura Medical beats Oxford BioDynamics on 7 of the 11 factors compared between the two stocks.

How does Futura Medical compare to Talisman Metals?

Talisman Metals (LON:TLM) and Futura Medical (LON:FUM) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, earnings, valuation, media sentiment, analyst recommendations, dividends, risk and institutional ownership.

Talisman Metals has a net margin of 0.00% compared to Futura Medical's net margin of -534.62%. Talisman Metals' return on equity of -32.71% beat Futura Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Talisman Metals	N/A	-32.71%	3.70%
Futura Medical	-534.62%	-310.00%	-26.59%

Talisman Metals has higher earnings, but lower revenue than Futura Medical. Futura Medical is trading at a lower price-to-earnings ratio than Talisman Metals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Talisman Metals	N/A	N/A	-£1.35M	£12.39	0.51
Futura Medical	£1.70M	1.51	-£3.88M	-£2.78	N/A

In the previous week, Talisman Metals and Talisman Metals both had 1 articles in the media. Talisman Metals' average media sentiment score of 0.21 beat Futura Medical's score of 0.00 indicating that Talisman Metals is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Talisman Metals	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Futura Medical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

1.4% of Talisman Metals shares are owned by institutional investors. Comparatively, 1.0% of Futura Medical shares are owned by institutional investors. 95.2% of Talisman Metals shares are owned by insiders. Comparatively, 16.0% of Futura Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Talisman Metals has a beta of 0.9, meaning that its share price is 10% less volatile than the broader market. Comparatively, Futura Medical has a beta of 0.021, meaning that its share price is 98% less volatile than the broader market.

Summary

Talisman Metals beats Futura Medical on 10 of the 11 factors compared between the two stocks.

How does Futura Medical compare to Burning Rock Biotech?

Futura Medical (LON:FUM) and Burning Rock Biotech (LON:BNR) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, earnings, institutional ownership, valuation, dividends, profitability and media sentiment.

1.0% of Futura Medical shares are held by institutional investors. 16.0% of Futura Medical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Burning Rock Biotech has lower revenue, but higher earnings than Futura Medical.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Futura Medical	£1.70M	1.51	-£3.88M	-£2.78	N/A
Burning Rock Biotech	N/A	N/A	N/A	N/A	N/A

Burning Rock Biotech has a net margin of 0.00% compared to Futura Medical's net margin of -534.62%. Burning Rock Biotech's return on equity of 0.00% beat Futura Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Futura Medical	-534.62%	-310.00%	-26.59%
Burning Rock Biotech	N/A	N/A	N/A

In the previous week, Futura Medical had 1 more articles in the media than Burning Rock Biotech. MarketBeat recorded 1 mentions for Futura Medical and 0 mentions for Burning Rock Biotech. Futura Medical's average media sentiment score of 0.00 equaled Burning Rock Biotech'saverage media sentiment score.

Company	Overall Sentiment
Futura Medical	Neutral
Burning Rock Biotech	Neutral

Summary

Futura Medical beats Burning Rock Biotech on 4 of the 7 factors compared between the two stocks.

How does Futura Medical compare to Nuformix?

Futura Medical (LON:FUM) and Nuformix (LON:NFX) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, profitability, media sentiment, earnings, risk, dividends, valuation and analyst recommendations.

Nuformix has lower revenue, but higher earnings than Futura Medical. Nuformix is trading at a lower price-to-earnings ratio than Futura Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Futura Medical	£1.70M	1.51	-£3.88M	-£2.78	N/A
Nuformix	N/A	N/A	-£383.40K	-£0.03	N/A

Futura Medical has a beta of 0.021, suggesting that its share price is 98% less volatile than the broader market. Comparatively, Nuformix has a beta of 1.519, suggesting that its share price is 52% more volatile than the broader market.

In the previous week, Futura Medical had 1 more articles in the media than Nuformix. MarketBeat recorded 1 mentions for Futura Medical and 0 mentions for Nuformix. Futura Medical's average media sentiment score of 0.00 equaled Nuformix'saverage media sentiment score.

Company	Overall Sentiment
Futura Medical	Neutral
Nuformix	Neutral

Nuformix has a net margin of 0.00% compared to Futura Medical's net margin of -534.62%. Nuformix's return on equity of -83.53% beat Futura Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Futura Medical	-534.62%	-310.00%	-26.59%
Nuformix	N/A	-83.53%	-17.20%

1.0% of Futura Medical shares are held by institutional investors. Comparatively, 0.1% of Nuformix shares are held by institutional investors. 16.0% of Futura Medical shares are held by insiders. Comparatively, 7.5% of Nuformix shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

Nuformix beats Futura Medical on 6 of the 11 factors compared between the two stocks.

How does Futura Medical compare to Motif Bio?

Futura Medical (LON:FUM) and Motif Bio (LON:MTFB) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, profitability, earnings, analyst recommendations, media sentiment, institutional ownership, dividends and valuation.

Motif Bio has lower revenue, but higher earnings than Futura Medical. Futura Medical is trading at a lower price-to-earnings ratio than Motif Bio, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Futura Medical	£1.70M	1.51	-£3.88M	-£2.78	N/A
Motif Bio	N/A	N/A	N/A	-£19.20	N/A

1.0% of Futura Medical shares are held by institutional investors. 16.0% of Futura Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Futura Medical had 1 more articles in the media than Motif Bio. MarketBeat recorded 1 mentions for Futura Medical and 0 mentions for Motif Bio. Futura Medical's average media sentiment score of 0.00 equaled Motif Bio'saverage media sentiment score.

Company	Overall Sentiment
Futura Medical	Neutral
Motif Bio	Neutral

Motif Bio has a net margin of 0.00% compared to Futura Medical's net margin of -534.62%. Motif Bio's return on equity of 0.00% beat Futura Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Futura Medical	-534.62%	-310.00%	-26.59%
Motif Bio	N/A	N/A	N/A

Summary

Futura Medical beats Motif Bio on 5 of the 9 factors compared between the two stocks.

Get Futura Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding FUM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

FUM vs. The Competition

Export

Metric	Futura Medical	Biotechnology Industry	Healthcare Sector	LON Exchange
Market Cap	£2.56M	£3.74B	£7.08B	£2.89B
Dividend Yield	4.55%	3.76%	2.58%	6.09%
P/E Ratio	-0.16	10.36	268.54	368.57
Price / Sales	1.51	1,270.17	651.20	83,659.40
Price / Cash	20.43	102.94	70.59	27.89
Price / Book	0.17	17.81	13.11	7.22
Net Income	-£3.88M	-£13.23M	£3.45B	£5.89B
7 Day Performance	10.00%	2.97%	1.81%	1.34%
1 Month Performance	10.00%	1.40%	0.90%	2.83%
1 Year Performance	-95.02%	55.32%	67.67%	70.18%

Futura Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
FUM Futura Medical	N/A	GBX 0.44 -8.9%	N/A	-94.4%	£2.56M	£1.70M	N/A	12	Gap Down
OBD Oxford BioDynamics	N/A	GBX 0.12 +14.3%	N/A	-62.7%	£5.15M	£1.20M	N/A	45	News Coverage Gap Down
TLM Talisman Metals	N/A	GBX 6.13 -2.0%	N/A	N/A	£3.93M	N/A	0.49	5
BNR Burning Rock Biotech	N/A	N/A	N/A	N/A	£3.77M	N/A	N/A	1,390	Gap Down High Trading Volume
NFX Nuformix	N/A	GBX 0.14 +7.0%	N/A	+55.4%	£3.60M	N/A	N/A	3	Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (LON:FUM) was last updated on 8/13/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Futura Medical (FUM) Competitors

FUM vs. OBD, TLM, BNR, NFX, and MTFB

How does Futura Medical compare to Oxford BioDynamics?

Summary

How does Futura Medical compare to Talisman Metals?

Summary

How does Futura Medical compare to Burning Rock Biotech?

Summary

How does Futura Medical compare to Nuformix?

Summary

How does Futura Medical compare to Motif Bio?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

FUM vs. The Competition

Futura Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Futura Medical (FUM) Competitors

FUM vs. OBD, TLM, BNR, NFX, and MTFB

How does Futura Medical compare to Oxford BioDynamics?

Is FUM or OBD more profitable?

Does the media prefer FUM or OBD?

Which has more volatility & risk, FUM or OBD?

Which has preferable earnings & valuation, FUM or OBD?

Do institutionals & insiders believe in FUM or OBD?

Summary

How does Futura Medical compare to Talisman Metals?

Is TLM or FUM more profitable?

Which has stronger earnings & valuation, TLM or FUM?

Does the media prefer TLM or FUM?

Do institutionals and insiders hold more shares of TLM or FUM?

Which has more risk and volatility, TLM or FUM?

Summary

How does Futura Medical compare to Burning Rock Biotech?

Do insiders and institutionals hold more shares of FUM or BNR?

Which has better earnings & valuation, FUM or BNR?

Is FUM or BNR more profitable?

Does the media favor FUM or BNR?

Summary

How does Futura Medical compare to Nuformix?

Which has preferable earnings and valuation, FUM or NFX?

Which has more volatility & risk, FUM or NFX?

Does the media prefer FUM or NFX?

Is FUM or NFX more profitable?

Do insiders & institutionals believe in FUM or NFX?

Summary

How does Futura Medical compare to Motif Bio?

Which has better valuation & earnings, FUM or MTFB?

Do insiders and institutionals hold more shares of FUM or MTFB?

Does the media favor FUM or MTFB?

Is FUM or MTFB more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

FUM vs. The Competition

Futura Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools